Cargando…

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells

OBJECTIVE: Sorafenib is a first-line drug for advanced hepatocellular carcinoma (HCC). Unfortunately, most patients with HCC do not respond to sorafenib, mainly because of the frequent development of drug resistance. Bilirubin is an end metabolite of heme catabolism and an indicator of liver functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Leyi, Zhao, Qian, Yan, Ding, Lei, Ziying, Hao, Yali, Chen, Jinghong, Xue, Qian, Li, Xiaofen, Huang, Qingtian, Tang, Daolin, Dou, Q. Ping, Chen, Xin, Liu, Jinbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334754/ https://www.ncbi.nlm.nih.gov/pubmed/35604090 http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0598

Ejemplares similares

Bilirubin inhibits lung carcinogenesis by up-regulating cystatin A expression in tumor-infiltrating macrophages
por: Huang, Qingtian, et al.
Publicado: (2023)

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling
por: Tan, Yufan, et al.
Publicado: (2021)

Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system
por: Wen, Guanmei, et al.
Publicado: (2022)

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
por: Chen, Xin, et al.
Publicado: (2017)

Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy
por: Li, Yanling, et al.
Publicado: (2021)

Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells
por: Yang, Li, et al.
Publicado: (2020)

Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30
por: Yan, Ding, et al.
Publicado: (2021)

The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability
por: Yang, Qianqian, et al.
Publicado: (2022)

Bilirubin neurotoxicity is associated with proteasome inhibition
por: Huang, Hongbiao, et al.
Publicado: (2017)

Copper-dependent autophagic degradation of GPX4 drives ferroptosis
por: Xue, Qian, et al.
Publicado: (2023)

Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy
por: Chen, Xin, et al.
Publicado: (2021)

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
por: Tai, W-T, et al.
Publicado: (2013)

FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
por: Tong, Jingshan, et al.
Publicado: (2016)

Pterostilbene enhances sorafenib’s anticancer effects on gastric adenocarcinoma
por: Zhao, Tingting, et al.
Publicado: (2020)

Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
por: Zhong, Bin-Yan, et al.
Publicado: (2020)

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
por: Li, Xuguang, et al.
Publicado: (2020)

Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment
por: Hu, Keshu, et al.
Publicado: (2021)

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy
por: Hsu, Wei-Fan, et al.
Publicado: (2022)

Role of Baseline Albumin-Bilirubin Grade on Predict Overall Survival Among Sorafenib-Treated Patients With Hepatocellular Carcinoma in Vietnam
por: Nguyen, Thi Thu Huong, et al.
Publicado: (2019)

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2021)

A new gold(I) complex-Au(PPh(3))PT is a deubiquitinase inhibitor and inhibits tumor growth
por: Li, Xiaofen, et al.
Publicado: (2018)

Causal relationships of neonatal jaundice, direct bilirubin and indirect bilirubin with autism spectrum disorder: A two-sample Mendelian randomization analysis
por: Chen, Li-wen, et al.
Publicado: (2023)

Timed degradation of Mcl-1 controls mitotic cell death
por: Clarke, Paul R., et al.
Publicado: (2018)

Serpinc1 Acts as a Tumor Suppressor in Hepatocellular Carcinoma Through Inducing Apoptosis and Blocking Macrophage Polarization in an Ubiquitin-Proteasome Manner
por: Xu, Dacai, et al.
Publicado: (2021)

Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene
por: Khazaei Koohpar, Zeinab, et al.
Publicado: (2015)

Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma
por: Wang, Zhexuan, et al.
Publicado: (2020)

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
por: Pignochino, Ymera, et al.
Publicado: (2009)

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Publicado: (2021)

Synthesis and Biological Evaluation of 4β-N-Acetylamino Substituted Podophyllotoxin Derivatives as Novel Anticancer Agents
por: Wei, Jinbao, et al.
Publicado: (2019)

A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
por: Lee, Erinna F., et al.
Publicado: (2008)

DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex
por: Nakajima, Wataru, et al.
Publicado: (2016)

Copper metabolism in cell death and autophagy
por: Xue, Qian, et al.
Publicado: (2023)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)

Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells
por: Luo, Lifang, et al.
Publicado: (2018)

Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma
por: Albalawi, Fahad, et al.
Publicado: (2023)

Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins
por: Wang, Haiyong, et al.
Publicado: (2018)

Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
por: Spagnuolo, C, et al.
Publicado: (2011)

Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
por: Gan, Yu, et al.
Publicado: (2023)

The VTLISFG motif in the BH1 domain plays a significant role in regulating the degradation of Mcl-1()
por: Xiao, Kang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7oado61ugkbg5icj3gir64cr9p